Sørensen Dag R, Leirdal Marianne, Sioud Mouldy
Department of Comparative Medicine, The National Hospital, Oslo 0310, Norway.
J Mol Biol. 2003 Apr 4;327(4):761-6. doi: 10.1016/s0022-2836(03)00181-5.
In mammalian cells, RNA duplexes of 21-23 nucleotides, known as small interfering RNAs (siRNAs) specifically inhibit gene expression in vitro. Here, we show that systemic delivery of siRNAs can inhibited exogenous and endogenous gene expression in adult mice. Cationic liposome-based intravenous injection in mice of plasmid encoding the green fluorescent protein (GFP) with its cognate siRNA, inhibited GFP gene expression in various organs. Furthermore, intraperitoneal injection of anti-TNF-alpha siRNA inhibited lipopolysaccharide-induced TNF-alpha gene expression, whereas secretion of IL1-alpha was not inhibited. Importantly, the development of sepsis in mice following a lethal dose of lipopolysaccharide injection, was significantly inhibited by pre-treatment of the animals with anti-TNF-alpha siRNAs. Collectively, these results demonstrate that synthetic siRNAs can function in vivo as pharmaceutical drugs.
在哺乳动物细胞中,21 - 23个核苷酸的RNA双链体,即小干扰RNA(siRNA),在体外能特异性抑制基因表达。在此,我们表明,系统性递送siRNA可抑制成年小鼠中外源和内源基因的表达。在小鼠中基于阳离子脂质体静脉注射编码绿色荧光蛋白(GFP)及其同源siRNA的质粒,可抑制GFP基因在各个器官中的表达。此外,腹腔注射抗TNF-α siRNA可抑制脂多糖诱导的TNF-α基因表达,而IL1-α的分泌未受抑制。重要的是,用抗TNF-α siRNA预处理动物可显著抑制小鼠在注射致死剂量脂多糖后败血症的发展。总体而言,这些结果表明合成siRNA可作为药物在体内发挥作用。